STAAR Surgical Net Change in Property, Plant, and Equipment 2010-2024 | STAA

STAAR Surgical net change in property, plant, and equipment from 2010 to 2024. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
STAAR Surgical Annual Net Change in Property, Plant, and Equipment
(Millions of US $)
2024 $-23
2023 $-18
2022 $-18
2021 $-14
2020 $-8
2019 $-10
2018 $-2
2017 $-1
2016 $-3
2015 $-2
2014 $-4
2013 $-3
2012 $-2
2011 $-1
2010 $0
2009 $-1
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.004B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $86.017B 20.77
Becton Dickinson (BDX) United States $50.254B 12.44
Cardinal Health (CAH) United States $35.472B 18.58
Straumann Holding AG (SAUHY) Switzerland $21.255B 0.00
Labcorp (LH) United States $21.004B 17.04
Cooper (COO) United States $16.886B 22.40
West Pharmaceutical Services (WST) United States $15.767B 33.05
Align Technology (ALGN) United States $13.700B 27.19
Henry Schein (HSIC) United States $8.578B 14.71
Merit Medical Systems (MMSI) United States $5.835B 28.21
DENTSPLY SIRONA (XRAY) United States $3.338B 9.97
CONMED (CNMD) United States $1.879B 14.06
Lifevantage (LFVN) United States $0.149B 15.40
Pro-Dex (PDEX) United States $0.131B 14.38